Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 08, 2019

SELL
$19.85 - $22.76 $239,351 - $274,440
-12,058 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$17.59 - $21.1 $212,100 - $254,423
12,058 New
12,058 $254,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.57B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Blackhawk Capital Partners Llc. Portfolio

Follow Blackhawk Capital Partners Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackhawk Capital Partners Llc., based on Form 13F filings with the SEC.

News

Stay updated on Blackhawk Capital Partners Llc. with notifications on news.